These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7054983)

  • 21. The bifid visual evoked potential-normal variant or a sign of demyelination?
    Rousseff RT; Tzvetanov P; Rousseva MA
    Clin Neurol Neurosurg; 2005 Feb; 107(2):113-6. PubMed ID: 15708225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed visual evoked potentials in multiple sclerosis: interpretation of VEP latencies for follow-up studies.
    Mauguière F; Brudon F; Challet E; Maraval G; Courjon J
    Adv Neurol; 1982; 32():443-52. PubMed ID: 7054968
    [No Abstract]   [Full Text] [Related]  

  • 23. [Visual evoked potentials and the E-UFA test. Laboratory contribution to the diagnosis of multiple sclerosis].
    Ghezzi A; Caputo D; Vanzulli F; Zibetti A
    Minerva Med; 1979 Sep; 70(42):2883-8. PubMed ID: 492555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French].
    De Seze J; Mackowiak A; Stojkovic T; Ferriby D; Hautecoeur P; Vermersch P
    Rev Neurol (Paris); 2002 Mar; 158(3):341-5. PubMed ID: 11976594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria.
    Simó M; Barsi P; Arányi Z
    Mult Scler; 2008 May; 14(4):472-8. PubMed ID: 18208873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical correlations and evoked potentials in 29 cases of definitive multiple sclerosis].
    Ferrer S; Jiménez P; Mellado L; Thieck E
    Rev Med Chil; 1993 Oct; 121(10):1154-60. PubMed ID: 8191120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visual evoked potentials in idiopathic intracranial hypertension.
    Kesler A; Vakhapova V; Korczyn AD; Drory VE
    Clin Neurol Neurosurg; 2009 Jun; 111(5):433-6. PubMed ID: 19345474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute posterior cord lesions in multiple sclerosis. An MRI study of the clinical course in 20 cases].
    Pou Serradell A; Roquer González J; Perich Alsina X
    Rev Neurol (Paris); 2000 Dec; 156(12):1126-35. PubMed ID: 11139729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.
    Samsen P; Chuenkongkaew WL; Masayaanon P; Chirapapaisan N; Ruangvaravate N; Loket S
    J Med Assoc Thai; 2007 Feb; 90(2):313-8. PubMed ID: 17375637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The diagnostic value of nuclear magnetic resonance tomography, multimodal evoked potentials and cerebrospinal fluid examination in multiple sclerosis].
    Staffen W; Trinka E; Ladurner G
    Nervenarzt; 1993 Apr; 64(4):226-32. PubMed ID: 8506010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum vitamin B12, folate, and homocysteine levels and their association with clinical and electrophysiological parameters in multiple sclerosis.
    Kocer B; Engur S; Ak F; Yilmaz M
    J Clin Neurosci; 2009 Mar; 16(3):399-403. PubMed ID: 19153046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in visual evoked potentials in patients with multiple sclerosis treated with isoprinosine and amantadine.
    Maciejek Z
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):621-8. PubMed ID: 2484835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence.
    Boster A; Caon C; Perumal J; Hreha S; Zabad R; Zak I; Tselis A; Lisak R; Khan O
    Mult Scler; 2008 Jul; 14(6):804-8. PubMed ID: 18573830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transient and steady-state electroretinograms and visual evoked potentials to pattern and uniform-field stimulation in humans].
    Nakayama M
    Fukuoka Igaku Zasshi; 1994 Jul; 85(7):225-34. PubMed ID: 8070753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vestibular evoked myogenic potentials in multiple sclerosis: a comparison between onset and definite cases.
    Alpini D; Pugnetti L; Caputo D; Cesarani A
    Int Tinnitus J; 2005; 11(1):48-51. PubMed ID: 16419689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodal evoked potentials in multiple sclerosis: basal and follow-up data.
    Gambi D; Rossini PM; Marchionno L; Iarlori T; Finarelli A; Pirchio M
    Adv Neurol; 1982; 32():551-7. PubMed ID: 7054984
    [No Abstract]   [Full Text] [Related]  

  • 38. [The cerebral refractory time of visual evoked potentials in normal persons and in patients with multiple sclerosis].
    Gerhard H; Jörg J
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1982 Jun; 13(2):77-81. PubMed ID: 6811243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sympathetic skin response: correlation with autonomic and somatic involvement in multiple sclerosis.
    Caminero AB; Pérez-Jiménez A; Barreiro P; Ferrer T
    Electromyogr Clin Neurophysiol; 1995 Dec; 35(8):457-62. PubMed ID: 8773205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.